The alignment of physicians with hospitals and health systems can be challenging in today’s healthcare climate, yet interest in alignment continues to expand. In some instances, the necessity of maintaining a strong and diverse medical staff coupled with the threat of losing critical team members and the subsequent closure of a business line may result in hospitals and health systems making decisions and promises they may not otherwise make.
Every medical practice is at risk for a natural or man-made disaster. Future events cannot be predicted, but responses to such events can be. Any medical professional who has worked through a disaster can tell you either how glad they are that the practice had a disaster plan in place, or how they regret the practice was not prepared for such a risk.
Louisville, KY—Members of the National Organization of Rheumatology Managers (NORM) met in Louisville, KY, September 12-13, 2014, for the group’s 2014 annual conference. Approximately 150 attendees gathered for the meeting, hailing from practices throughout the United States.
An expert recently shared the pitfalls of noncompliance with breach-reporting provisions that came into effect last year under the US Department of Health & Human Services (HHS) Health Insurance Portability and Accountability Act (HIPAA) and Health Information Technology for Economic and Clinical Health Act.
Rheumatology managers recently received an overview of Medicare local coverage determinations (LCDs) that will be used when the International Classification of Diseases, Tenth Edition (ICD-10) takes effect in 2015. At the National Organization of Rheumatology Managers (NORM) 2014 Annual Conference, Jean Acevedo, president, Acevedo Consulting Incorporated, Delray Beach, FL, discussed the ins and outs of LCDs, providing tips and practical solutions.
My first experience with documentation outside of a hospital was at a small internal medicine office in Richmond, VA. I was a fourth-year medical student, and the supervising internist ran a small, but very nice office near Stuart Circle. He spent a lot of time with each patient and very little time dictating a few sentences about each encounter for the patient’s medical record.
There is a growing need for dedicated healthcare providers from rheumatology private practice to step into the role of researcher and participate in clinical trials to evaluate treatment regimens and therapies.
The Food and Drug Administration (FDA) recently took initial steps toward regulating laboratory-developed tests (LDTs). Used to select appropriate treatment for individual patients, LDTs are designed, made, and used within a single laboratory, and include genetic tests and tests used by clinicians to guide their patients’ treatment.
Results 1 - 8 of 8